These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27856625)

  • 21. The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease.
    Hume SP; Lammertsma AA; Myers R; Rajeswaran S; Bloomfield PM; Ashworth S; Fricker RA; Torres EM; Watson I; Jones T
    J Neurosci Methods; 1996 Aug; 67(2):103-12. PubMed ID: 8872875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MR-based spatial normalization improves [18F]MNI-659 PET regional quantification and detectability of disease effect in the Q175 mouse model of Huntington's disease.
    Bertoglio D; Verhaeghe J; Kosten L; Thomae D; Van der Linden A; Stroobants S; Wityak J; Dominguez C; Mrzljak L; Staelens S
    PLoS One; 2018; 13(10):e0206613. PubMed ID: 30365550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral PET imaging and histological evidence of transglutaminase inhibitor cystamine induced neuroprotection in transgenic R6/2 mouse model of Huntington's disease.
    Wang X; Sarkar A; Cicchetti F; Yu M; Zhu A; Jokivarsi K; Saint-Pierre M; Brownell AL
    J Neurol Sci; 2005 Apr; 231(1-2):57-66. PubMed ID: 15792822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved synthesis of [
    Huhtala T; Poutiainen P; Rytkönen J; Lehtimäki K; Parkkari T; Kasanen I; Airaksinen AJ; Koivula T; Sweeney P; Kontkanen O; Wityak J; Dominiquez C; Park LC
    EJNMMI Radiopharm Chem; 2019 Aug; 4(1):20. PubMed ID: 31659519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cortical dopamine D2/D3 receptors and verbal memory in man.
    Lumme V; Hirvonen MM; Ilonen T; Hirvonen J; Någren K; Hietala J
    Neuroimage; 2010 Jun; 51(2):918-22. PubMed ID: 20188195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease.
    Araujo DM; Cherry SR; Tatsukawa KJ; Toyokuni T; Kornblum HI
    Exp Neurol; 2000 Dec; 166(2):287-97. PubMed ID: 11085894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TSPO-PET imaging using [18F]PBR06 is a potential translatable biomarker for treatment response in Huntington's disease: preclinical evidence with the p75NTR ligand LM11A-31.
    Simmons DA; James ML; Belichenko NP; Semaan S; Condon C; Kuan J; Shuhendler AJ; Miao Z; Chin FT; Longo FM
    Hum Mol Genet; 2018 Aug; 27(16):2893-2912. PubMed ID: 29860333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation in rats of the dopamine D2/3 receptor agonist 18F-AMC20 as a potential radioligand for PET.
    Shalgunov V; van Wieringen JP; Janssen HM; Fransen PM; Dierckx RA; Michel MC; Booij J; Elsinga PH
    J Nucl Med; 2015 Jan; 56(1):133-9. PubMed ID: 25476538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.
    Abi-Dargham A; Simpson N; Kegeles L; Parsey R; Hwang DR; Anjilvel S; Zea-Ponce Y; Lombardo I; Van Heertum R; Mann JJ; Foged C; Halldin C; Laruelle M
    Synapse; 1999 May; 32(2):93-109. PubMed ID: 10231129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabotropic Glutamate Receptor 2/3 Activation Improves Motor Performance and Reduces Pathology in Heterozygous zQ175 Huntington Disease Mice.
    Li SH; Colson TL; Abd-Elrahman KS; Ferguson SSG
    J Pharmacol Exp Ther; 2021 Oct; 379(1):74-84. PubMed ID: 34330748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriers.
    Pavese N; Politis M; Tai YF; Barker RA; Tabrizi SJ; Mason SL; Brooks DJ; Piccini P
    Neurobiol Dis; 2010 Feb; 37(2):356-61. PubMed ID: 19853661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antisense oligonucleotide-mediated correction of transcriptional dysregulation is correlated with behavioral benefits in the YAC128 mouse model of Huntington's disease.
    Stanek LM; Yang W; Angus S; Sardi PS; Hayden MR; Hung GH; Bennett CF; Cheng SH; Shihabuddin LS
    J Huntingtons Dis; 2013; 2(2):217-28. PubMed ID: 25063516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesia.
    Zhou X; Doorduin J; Elsinga PH; Dierckx RAJO; de Vries EFJ; Casteels C
    Neuroimage; 2017 Aug; 157():209-218. PubMed ID: 28583881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-sectional and longitudinal small animal PET shows pre and post-synaptic striatal dopaminergic deficits in an animal model of HIV.
    Sinharay S; Lee D; Shah S; Muthusamy S; Papadakis GZ; Zhang X; Maric D; Reid WC; Hammoud DA
    Nucl Med Biol; 2017 Dec; 55():27-33. PubMed ID: 29031113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clozapine binds preferentially to cortical D1-like dopamine receptors in the primate brain: a PET study.
    Chou YH; Halldin C; Farde L
    Psychopharmacology (Berl); 2006 Mar; 185(1):29-35. PubMed ID: 16395606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No effect of dopamine depletion on the binding of the high-affinity D 2/3 radiotracer [11C]FLB 457 in the human cortex.
    Frankle WG; Mason NS; Rabiner EA; Ridler K; May MA; Asmonga D; Chen CM; Kendro S; Cooper TB; Mathis CA; Narendran R
    Synapse; 2010 Dec; 64(12):879-85. PubMed ID: 20506387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-related changes of dopamine D1-like and D2-like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography.
    Suzuki M; Hatano K; Sakiyama Y; Kawasumi Y; Kato T; Ito K
    Synapse; 2001 Sep; 41(4):285-93. PubMed ID: 11494399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced D
    Weiss AR; Bertoglio D; Liguore WA; Brandon K; Templon J; Link J; McBride JL
    Mov Disord; 2023 Jan; 38(1):143-147. PubMed ID: 36544385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of striatal dopamine D2/D3 receptor availability with PET and 18F-desmethoxyfallypride: comparison of imaging protocols suited for clinical routine.
    Amtage F; Spehl TS; Hellwig S; Sahm U; Hellwig B; Reuland P; Weiller C; Weber WA; Winkler C; Meyer PT
    J Nucl Med; 2012 Oct; 53(10):1558-64. PubMed ID: 22899645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [123I]Epidepride neuroimaging of dopamine D2/D3 receptor in chronic MK-801-induced rat schizophrenia model.
    Huang YR; Shih JM; Chang KW; Huang C; Wu YL; Chen CC
    Nucl Med Biol; 2012 Aug; 39(6):826-32. PubMed ID: 22464847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.